Navidea Biopharmaceuticals Inc (NAVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NAVB | TMO | ISRG | ALC | EW |
| Company | Navidea Biopharmaceuticals Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Alcon Inc | Edwards Lifesciences Corp |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NYSE | NYSE |
| Open | 0.0010 | 514.62 | 549.84 | 85.96 | 70.31 |
| High | 0.0010 | 517.00 | 552.00 | 86.24 | 71.00 |
| Low | 0.0010 | 507.17 | 541.99 | 85.65 | 69.96 |
| Last | 0.0010 | 513.26 | 547.87 | 85.99 | 70.48 |
| Change | unch | -2.84 | -2.75 | +0.42 | +0.10 |
| % Change | unch | -0.55% | -0.50% | +0.49% | +0.14% |
| Volume | 50,300 | 1,833,500 | 1,375,500 | 452,000 | 2,711,600 |
| 20-Day Average Volume | 9,250 | 1,783,400 | 1,319,595 | 1,096,880 | 5,117,705 |
| Previous Close | 0.0010 | 516.10 | 550.62 | 85.57 | 70.38 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0009 | 538.35 | 526.79 | 89.65 | 67.77 |
| 20-Day Raw Stochastic | 100.00% | 25.96% | 91.95% | 18.45% | 77.00% |
| 20-Day Relative Strength | 45.95% | 31.34% | 66.56% | 31.61% | 57.21% |
| Weighted Alpha | -47.05 | -4.51 | +72.94 | +9.95 | +7.82 |
| Today's Opinion | 80% Sell | 88% Sell | 100% Buy | 24% Sell | 24% Sell |
| Previous Opinion | 80% Sell | 88% Sell | 100% Buy | 24% Sell | 40% Sell |
| Last Month's Opinion | 80% Sell | 8% Sell | 100% Buy | 40% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 11/15/24 | +0.04% since 11/15/24 | +3.84% since 11/15/24 | +1.01% since 11/15/24 | +4.01% since 11/15/24 |
| Low | 0.0010 on 11/22/24 | 493.30 on 11/19/24 | 526.01 on 11/19/24 | 84.28 on 11/18/24 | 67.58 on 11/18/24 |
| High | 0.0010 on 11/22/24 | 517.00 on 11/22/24 | 552.00 on 11/22/24 | 86.86 on 11/18/24 | 71.08 on 11/18/24 |
| 1-Month | |||||
| %Chg | unch since 10/22/24 | -12.47% since 10/22/24 | +5.87% since 10/22/24 | -9.14% since 10/22/24 | +1.79% since 10/22/24 |
| Low | 0.0002 on 11/05/24 | 493.30 on 11/19/24 | 500.67 on 10/31/24 | 83.92 on 11/15/24 | 64.89 on 11/12/24 |
| High | 0.0010 on 11/22/24 | 578.69 on 10/23/24 | 552.00 on 11/22/24 | 95.14 on 10/28/24 | 72.15 on 10/28/24 |
| 3-Month | |||||
| %Chg | unch since 08/21/24 | -15.00% since 08/22/24 | +11.71% since 08/22/24 | -9.80% since 08/22/24 | -1.15% since 08/22/24 |
| Low | 0.0002 on 11/05/24 | 493.30 on 11/19/24 | 466.00 on 09/06/24 | 83.92 on 11/15/24 | 64.00 on 10/07/24 |
| High | 0.1300 on 09/30/24 | 627.88 on 09/10/24 | 552.00 on 11/22/24 | 101.10 on 09/12/24 | 72.15 on 10/28/24 |
| 6-Month | |||||
| %Chg | -96.67% since 05/20/24 | -13.12% since 05/22/24 | +36.66% since 05/22/24 | -5.25% since 05/22/24 | -21.87% since 05/22/24 |
| Low | 0.0001 on 06/27/24 | 493.30 on 11/19/24 | 396.15 on 05/29/24 | 83.92 on 11/15/24 | 58.93 on 07/25/24 |
| High | 0.1300 on 09/30/24 | 627.88 on 09/10/24 | 552.00 on 11/22/24 | 101.10 on 09/12/24 | 95.25 on 07/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 100 | 196,321,952 | 195,139,776 | 42,414,048 | 41,569,104 |
| Shares Outstanding, K | 100,084 | 382,500 | 356,179 | 493,244 | 589,800 |
| Annual Sales | 70,000 | 42,857,000,000 | 7,124,100,000 | 9,455,000,000 | 6,004,800,000 |
| Annual Net Income | -15,180,000 | 5,995,000,000 | 1,798,000,000 | 974,000,000 | 1,402,400,000 |
| Last Quarter Sales | 0 | 10,598,000,000 | 2,038,100,000 | 2,454,000,000 | 1,354,400,000 |
| Last Quarter Net Income | -2,260,000 | 1,629,000,000 | 565,100,000 | 263,000,000 | 3,070,800,000 |
| 60-Month Beta | 1.45 | 0.79 | 1.39 | 0.99 | 1.12 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 08/11/23 | 5.28 on 10/23/24 | 1.84 on 10/17/24 | 0.81 on 11/12/24 | 0.67 on 10/24/24 |
| Latest Earnings Date | 11/26/24 | 10/23/24 | 10/17/24 | 11/12/24 | 10/24/24 |
| Most Recent Dividend | N/A | 0.390 on 09/13/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 12/13/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 24.08 | 102.54 | 28.24 | 26.36 |